(Q37149087)

18 August 2017

1 reference

title

The use of clinical utility assessments in early clinical development (English)

1 reference

18 August 2017

Anis A Khan

1

1 reference

18 August 2017

Itay Perlstein

series ordinal

2

1 reference

18 August 2017

Rajesh Krishna

series ordinal

3

1 reference

18 August 2017

language of work or name

English

0 references

publication date

16 January 2009

1 reference

18 August 2017

1 reference

18 August 2017

11

1 reference

18 August 2017

1

1 reference

18 August 2017

33-38

1 reference

https://scigraph.springernature.com/pub.10.1208/s12248-008-9074-z

18 August 2017

0 references

cites work

Decision analysis and Markov modeling in urology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664875

Pharmacometrics and the transition to model-based development

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664875

Primer: using decision analysis to improve clinical decision making in urology

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664875

Pharmacokinetic-pharmacodynamic modeling in the data analysis and interpretation of drug-induced QT/QTc prolongation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664875

Review of guidelines for good practice in decision-analytic modelling in health technology assessment

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664875

Can the pharmaceutical industry reduce attrition rates?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664875

Determination of an optimal dosage regimen using a Bayesian decision analysis of efficacy and adverse effect data

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664875

Combining drug-disease and economic modelling to inform drug development decisions

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664875

Analysing clinical decision analyses

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664875

A rational framework for decision making by the National Institute For Clinical Excellence (NICE).

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664875

Learning versus confirming in clinical drug development

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664875

Modelling a spontaneously reported side effect by use of a Markov mixed-effects model

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664875

Exposure-response analysis for spontaneously reported dizziness in pregabalin-treated patient with generalized anxiety disorder

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664875

Using pharmacokinetic/pharmacodynamic modelling in safety pharmacology to better define safety margins: a regional workshop of the Safety Pharmacology Society.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664875

Schizophrenia: multi-attribute utility theory approach to selection of atypical antipsychotics.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664875

Bayesian dose-finding in phase I/II clinical trials using toxicity and efficacy odds ratios.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664875

Risk classification of Medicare HMO enrollee cost levels using a decision-tree approach.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664875

A multiattribute-utility-function approach to weighing the risks and benefits of pharmaceutical agents.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664875

A critique of the decision analysis for clinically localized prostate cancer.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664875

Model-based drug development applied to oncology

3 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19145490

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Decision theory in cancer therapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19145490

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1208/S12248-008-9074-Z

1 reference

Dimensions Publication ID

18 August 2017

0 references

1 reference

18 August 2017

PubMed publication ID

19145490

1 reference